ReBlood Rx

Thanksgiving is fast approaching and ReBlood Rx is thankful for the hard work of every member of our team, the guidance of our mentors and advisors, and the support of our family, friends and network! ?? Big News: Our CEO, Carlos J. Munoz, had the opportunity to pitch to Angels and Managing Partners during an investor roadshow put on by 757 Collab! ?? Achievements: Our team is extremely excited to announce that we are in conversations with Cannon Virginia to explore the potential of a contract manufacturing partnership! ?? Opportunities: With investor pitching in full swing, if you or a colleague are interested in scheduling a meeting or would like to review our pitch, please reach out to us! To read the full newsletter, please see below! #ReBloodRx #HealthTech #Innovation #StartupLife

So excited to kick off the 6th annual IGE UC San Diego Showcase with over 25 Startups tabling. This year’s theme is “Game- Changing Impact” with a focus on our MedTech Startups. Leading the event is an invite-only investor preview with 9 investor-ready startups pitching. Investable Startups Veera GolTech ReBlood Rx Mercury Alert AI AIR Surgical, Inc. Vesica AI Channel Robotics Kato Medical Limber Prosthetics & Orthotics Dennis Abremski Rebecca Deller Sujit Dey Albert "Al" P. Pisano, Ph.D. Sinan G?lhan Carlos J. Munoz Ji Lee Dimitri Schreiber Albert Liu, PhD Michael Yip Philip A. Weissbrod, MD Joshua Pelz Albert Hill Sai Zhou Mridu Sinha Arshan Ommid #igemedtech #medtech #innovations

Exciting News!??? ReBlood Rx is hitting the road for a week of pitch events as part of the 757 Accelerate Investor Roadshow! We're thrilled to be joining eight other startups to present at?five investor events, starting Monday,?October 14th?in North Carolina and wrapping up Thursday,?October 17th?in Virginia. Our goal is to engage?100 investors?over the week, so if you're an accredited investor—or know someone who is—this is a fantastic opportunity to hear our pitch and connect! Register today?and get all the details here: https://lnkd.in/gSVJbk99 Can’t make it? No worries! Reach out to us directly, and we’d be happy to schedule a time to share our vision. ?? #757Accelerate #ReBloodRx #HealthTech #Startup #Innovation

Presenting a roundup of incredible achievements from our trailblazing alumni companies! Their milestones and inspiring success stories are not to be missed. Check out the highlights in the comments below, and don’t forget to subscribe to our new #SustainabilityInnovators monthly newsletter for more! ? ?? AirVitalize Innovations raises $155,000+ in non-dilutive funding, files an international patent, and secures a paid winter pilot for Fairbanks. ?? Gradible participates in the Green Sports Alliance Summit. ?? Founder of SEED - Sustainable Entrepreneurial Ecosystem Development, Sabrina Williams ??, gets featured in Bold Journey. ?? RxPost gets selected as a top 10 finalist for the Women Founders Network 2024 Fast Pitch Event. ?? ReBlood Rx accepted into 757 Accelerate’s Cohort 7. ?? Kind Designs gets featured on the PodBean podcast in The Contrarian Tide-Turner: Anya Freeman on Leading Kind Designs. ?? Apptronik demonstrates humanoid robot Apollo at IMTS. ?? Aquaria CEO Brian Sheng gets featured in The Impact At Scale podcast. ?? RabbleHealth partners with Asthma and Allergy Foundation of America to lead advocacy on implementation science & patient empowerment in asthma. ?? Suma recognized in Pacific Coast Business Times 40 Under 40, Prime Health Innovation Challenge, and Anthem Awards. ?? Get the full scoop here: https://lnkd.in/e6peYqkw ?? Don’t miss out! Subscribe to our newsletter: https://lnkd.in/gtcdE6J2 Let’s amplify these wins together! ?? #Sustainability #Innovation #ClimateAction #HealthTech #ClimateTech #LartaInstitute

How can we revolutionize emergency care in environments where traditional blood transfusions aren't possible? Our #HealLA 2024 cohort member, ReBlood Rx, is developing polymerized hemoglobin-based oxygen carriers (HBOCs) designed to improve remote damage control resuscitation (RDCR). This groundbreaking technology, led by founders Carlos J. Munoz, CEO, and Christopher Caballero, COO, targets environments where traditional crystalloids fall short due to their lack of oxygen-carrying capacity, offering a practical substitute for blood transfusions. ?? Carlos J. Munoz shares, "In the next 5-10 years, ReBlood Rx envisions a fully cleared FDA product for pre-hospital care situations where blood is needed but not available, increasing medical capabilities for people living in rural environments." This innovation has the potential to revolutionize field medicine, eliminating the need for refrigeration, crossmatching, and supply issues, ultimately enhancing the care provided by combat medics and pre-hospital care providers. We are proud to support ReBlood Rx, as they aim to transform emergency care and increase accessibility for all. ?? ____ HealLA provides a free, nine-month accelerator program aimed at nurturing and scaling innovations that address healthcare insecurity, inequities, and lack of preventive care. The HealLA Bioscience and Healthcare Accelerator is supported by esteemed partners such as the California Office of the Small Business Advocate (CalOSBA), U.S. Small Business Administration (SBA), Gilead Sciences, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, BioscienceLA, Cedars-Sinai, Keck School of Medicine of the University of Southern California, UCLA Technology Development Group, Biocom California, MedTech Color, Consortium for Technology & Innovation in Pediatrics (CTIP), California State University, Los Angeles, City of Hope, BioLabs, Rio Hondo College, Alliance for Southern California Innovation, Rancho Los Amigos National Rehabilitation Center, Keck Graduate Institute, WuXi Biologics. Learn more about the HealLA Bioscience and Healthcare Accelerator: https://lnkd.in/gi94ZB_f Discover the 2024 HealLA cohort: https://lnkd.in/gKRdHdzm #EmergencyCareInnovation #HBOCs #FieldMedicine #RemoteResuscitation #HealthcareInnovation #HealLA

As the summer comes to a close, ReBlood continues to turn up the heat. ReBlood Rx is hard at work to bring our innovation to the world! ?? Big News: Our team would like to thank the Center for Veterinary Medicine (CVM) for granting ReBlood Rx an ADUFA Fee Waiver, saving us over $900,000! ?? Achievements: Our team is extremely excited to be working with 757 Collab, to prepare us to pitch to various Angel groups from Washington D.C., Virginia, and North Carolina in October! ?? Opportunities: We would love to hear your thoughts about HBOC use in the Veterinarian Market. If you have experience using previous HBOCs, please reach out to us! ?? Gratitude: Thank you to Larta Institute’s Heal.LA program for continuing to provide us access to the mentorship of industry experts! To read the full September newsletter, please see below! #ReBloodRx #HealthTech #Innovation #StartupLife

Meet the faces behind ReBlood Rx, part of 757 Accelerate cohort 7! Learn more more ReBlood Rx today-https://ow.ly/B0FH50Tlo9k #757Accelerate

We're excited to share that ReBlood Rx, one of our current HealLA cohort companies, has been given the incredible opportunity to present its groundbreaking work at this year's Military Health System Research Symposium (MHSRS) in Orlando, Florida! ReBlood Rx will be presenting in the breakout session titled Remote Damage Control Resuscitation (RDCR): Innovations to Prolong the "Golden Hour" on Tuesday, August 27th, from 3:30 PM to 5:30 PM at the Gaylord Palms Resort & Convention Center in Kissimmee, FL. This is a significant milestone for ReBlood Rx as they showcase their innovative solutions aimed at saving lives in critical situations. Don't miss out on this important discussion and join us in supporting ReBlood Rx at MHSRS! ?? Event Date: August 27th ?? Location: Gaylord Palms Resort & Convention Center, Kissimmee, FL ?? Registration Link: https://www.mhsrs.net/ Carlos J. Munoz Christopher Caballero #MHSRS2024 #HealLA #ReBloodRx #GoldenHour #RemoteResuscitation #HealthcareInnovation